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Background: The COINCIDE trial aims to evaluate the effectiveness and cost-effectiveness of a collaborative care
intervention for depression in people with diabetes and/or coronary heart disease attending English general practices.
Design: This update details changes to the cluster and patient recruitment strategy for the COINCIDE study. The
original protocol was published in Trials (http://www.trialsjournal.com/content/pdf/1745-6215-13-139.pdf).
Modifications were made to the recruitment targets in response to lower-than-expected patient recruitment at the first
ten general practices recruited into the study. In order to boost patient numbers and retain statistical power, the
number of general practices recruited was increased from 30 to 36. Follow-up period was shortened from 6 months to
4 months to ensure that patients recruited to the trial could be followed up by the end of the study.
Results: Patient recruitment began on the 01/05/2012 and is planned to be completed by the 30/04/2013.
Recruitment for general practices was completed on 31/10/2012, by which time the target of 36 practices had been
recruited. The main trial results will be published in a peer-reviewed journal.
Conclusion: The data from the trial will provide evidence on the effectiveness and cost-effectiveness of collaborative
care for depression in people with diabetes and/or coronary heart disease.
Trial registration: Trial registration number: ISRCTN80309252
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Introduction
The Collaborative Interventions for Circulation and De-
pression (COINCIDE) trial aims to investigate the effec-
tiveness and cost-effectiveness of a collaborative care
intervention for depression for people with diabetes and/or
coronary heart disease [1]. The study is a cluster-
randomised controlled trial conducted in English general
practices. General practices were randomised to either a
collaborative care arm or a usual care arm. The primary
outcome is change in depression severity, as measured
on the symptoms checklist-90 (SCL-90).
Eligible patients will be listed on Quality and Out-
comes Framework disease registers for diabetes and/or
coronary heart disease at the participating general prac-
tices. Due to poor detection rates and under-referral for
treatment for depression in primary care in the UK,
consenting patients will be screened for depression by
the trial team using the Patient Health Questionnaire-9
(PHQ-9) on two occasions, two weeks apart. Patients
will be considered to be depressed if they return PHQ-9
scores ≥10 on both occasions. Patients will be excluded
from the study if they have a current diagnosis of de-
mentia, are currently receiving a psychosocial interven-
tion for depression, or treatment for drug or alcohol
dependence.Study progress
Patient and GP practice recruitment
General practice recruitment began on 3 January 2012.
The patient recruitment phase of the trial began when the
first patient was recruited into the study on 1 May 2012.
The average number of patients recruited per practice
was assessed after the first eleven practices had finished
recruitment. The average number of patients for these
practices was 10 (range 4 to 22), below the target figure
of 15 per practice.
The Trial Steering Committee (TSC) met on 17/10/12
when strategies for enhancing recruitment into the trial
were discussed. It was agreed that the most efficient
method to improve patient recruitment was to increase
the number of general practices in the trial and to re-
duce the follow-up period. Ethical and research gover-
nance approval (see Amendment 9 from the NRES
Committee North West - Preston, REF 11/NW/0742)
was therefore sought to revise the sample size. To en-
sure that we retained power to detect a difference in the
main outcome measure (SCL-90) we increased the num-
ber of clusters from 30 to 36. If we recruit 10 patients
per practice then we anticipate a final sample size of
360. With an average of 10 patients over 36 practices
(18 control/18 intervention) the study will have 79.1%
power to detect a moderate standardised effect size of0.4 at the 5% level of significance, allowing for an
intraclass correlation (ICC) of 0.06.
GP and patient recruitment ran concurrently until 31
October 2012, when the target of 36 general practices
was achieved.
Follow-up
To take into account the additional time needed to recruit
patients from six additional clusters, baseline patient
recruitment was extended until 30 April 2013. Ethical
and research governance approval (see Amendment 9
from the NRES Committee North West - Preston, REF
11/NW/0742) was granted to reduce the follow-up period
from six to four months, owing to the need to complete all
follow-up before the end-of-study date on 30 September
2013. Follow-up at four months post randomisation has
been used in other depression trials in primary care and is
the earliest time point that we might anticipate detecting a
treatment effect [2].
Discussion
Modifications to cluster and patient recruitment targets
following feedback to the TSC have offered opportunities
for this trial to retain adequate statistical power and deliver
on all aims and objectives. This process underlines the im-
portance of regular scrutiny of study progress by both the
research and project management team and by indepen-
dent monitors, such as a TSC [3].
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